MVX tracks mortality across several cohorts, but nobody has shown that lowering the score improves survival, or what a healthy person should do with the result.
I have three Thorne products in my cabinet. Here is what the P&G Thorne acquisition actually changes, based on the brands bought before it.
A trademark, a Netflix series, and about $100,000 a year for a city to keep the certification. The business kept growing while the science underneath it kept shrinking.
Updated September 7, 2026 with the HERMES and ATHENA trials both stopped early. ZEUS lowered inflammation exactly as designed and did not cut cardiovascular events. That weakens hs-CRP as something to treat, not as something worth measuring. Update, August 22, 2026: the people behind the colchicine trials have answered ZEUS, and a new UK Biobank
Both drugs block PCSK9 and cut LDL by about the same amount. Repatha is available now and cheap for most insured people. Lipfendra saves you the needle but asks for a daily fasting window, and paying cash it costs $89 to $117 a month more than the shot.
My TRT clinic prescribed 5 mg of tadalafil a day. Here is what it is actually proven to do for the prostate and ED, what the podcasts oversell, and the one drug interaction to never ignore.
A single low testosterone reading isn’t a diagnosis. I’m on TRT, and here’s how low testosterone is actually diagnosed, what TRT does, and the fertility risk young men miss.
I take a diabetes drug and have never had diabetes. A plain-English map of the type 2 diabetes drugs, and why the best ones now protect your heart and kidneys, not just blood sugar.
The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor. What it costs, how the pill compares to the shots, and who actually needs it.
A million-person Lancet study shows older adults with obesity now match normal-weight peers on blood pressure and cholesterol, thanks to cheap statins and blood-pressure pills, not weight loss.
